beta-alanine has been researched along with Cranial Nerve II Injuries in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shaw, PX | 1 |
| Sang, A | 1 |
| Wang, Y | 1 |
| Ho, D | 1 |
| Douglas, C | 1 |
| Dia, L | 1 |
| Goldberg, JL | 1 |
1 other study available for beta-alanine and Cranial Nerve II Injuries
| Article | Year |
|---|---|
Topical administration of a Rock/Net inhibitor promotes retinal ganglion cell survival and axon regeneration after optic nerve injury.
Topics: Administration, Topical; Animals; Axons; Benzoates; beta-Alanine; Blotting, Western; Cell Survival; | 2017 |